Validation of a DNA Methylation Signature of Favorable Prognosis in Newly Diagnosed Acute Myeloid Leukemia.

被引：0
|
作者：
Taby, Rodolphe F. [1 ]
Yellapragada, Sarvari Venkata [2 ,3 ]
Kroeger, Heike [1 ]
He, Rong [1 ]
Kornblau, Steven M. [4 ]
Kantarjian, Hagop [1 ]
Ravandi, Farhad [1 ]
Jelinek, Jaroslav [1 ]
Issa, Jean-Pierre J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Dept Hematol Oncol, Houston, TX USA
[3] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：645 / 645
页数：1
相关论文
共 50 条
  • [41] Origins of aberrant DNA methylation in acute myeloid leukemia
    Schoofs, T.
    Berdel, W. E.
    Mueller-Tidow, C.
    LEUKEMIA, 2014, 28 (01) : 1 - 14
  • [42] Origins of aberrant DNA methylation in acute myeloid leukemia
    T Schoofs
    W E Berdel
    C Müller-Tidow
    Leukemia, 2014, 28 : 1 - 14
  • [43] Updates on DNA methylation modifiers in acute myeloid leukemia
    Contieri, Bruna
    Duarte, Bruno Kosa Lino
    Lazarini, Mariana
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 693 - 701
  • [44] DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
    Jian, Jimo
    Yuan, Chenglu
    Ji, Chunyan
    Hao, Hongyuan
    Lu, Fei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2639 - 2649
  • [45] DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
    Jimo Jian
    Chenglu Yuan
    Chunyan Ji
    Hongyuan Hao
    Fei Lu
    Clinical and Experimental Medicine, 2023, 23 : 2639 - 2649
  • [46] Hematologic improvements with ivosidenib plus azacitidine compared to placebo plus azacitidine in patients with newly diagnosed acute myeloid leukemia.
    Dohner, Hartmut
    Montesinos, Pau
    Polo, Susana Vives
    Zarzycka, Ewa
    Wang, Jianxiang
    Bertani, Giambattista
    Heuser, Michael
    Calado, Rodrigo T.
    Schuh, Andre C.
    Yeh, Su-Peng
    Burguera, Adolfo de la Fuente
    Cerchione, Claudio
    Daigle, Scott
    Hui, Jianan
    Pandya, Shuchi Sumant
    Gianolio, Diego A.
    Recher, Christian
    De Botton, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Sequential flavopiridol, mitoxantrone and cytosine arabinoside for newly diagnosed poor risk acute myeloid leukemia. What to do next?
    van der Jagt, Richard H. C.
    LEUKEMIA RESEARCH, 2010, 34 (07) : 856 - 857
  • [48] A prospective study of all-trans retinoic acid plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia.
    Gu, Chengyuan
    Wang, Ruju
    Kang, Huizhu
    He, Xuefeng
    Chen, Jun
    Lin, Zhihong
    Liu, Yuejun
    Yang, Ting
    Wu, Depei
    Han, Yue
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Phase I/II study of sapacitabine and decitabine administered sequentially in elderly patients with newly diagnosed acute myeloid leukemia.
    Ravandi, F.
    Faderl, S.
    Cortes, J. E.
    Garcia-Manero, G.
    Jabbour, E.
    Boone, P. A.
    Kadia, T. M.
    Borthakur, G.
    Wierda, W. G.
    Chiao, J. H.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia
    Chen, Sarah M.
    Silyerman, Dustin A.
    Jatana, Kris R.
    Chiang, Tendy
    Guinipero, Terri
    Hill, Nina
    Siu, Jason J.
    Reed, Suzanne
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 122 : 126 - 129
12345